FDA deal leads to recall of infusion pumps

New York Times, May 4, 2010
Baxter International is recalling its Colleague infusion pumps from the American market under an agreement with federal regulators that sought to fix problems like battery failures and software errors. The Food and Drug Administration said on April 23 that infusion pumps used to administer drugs and liquids were linked to more than 56,000 complaints of injuries, deaths, and malfunctions from 2005 to 2009. The Baxter Healthcare Corporation, the company's principal American subsidiary, has been under a consent decree with the FDA since June 2006 that allowed the agency to require a recall of the pumps, the company said.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.